Efficacy and Safety of Percutaneous Liver Biopsy With Needle Tract Plugging on Outpatient Basis
COGEL
1 other identifier
interventional
122
1 country
1
Brief Summary
A prospective, randomized, two-arm, single-center study to compare efficacy and safety of percutaneous ultrasound-guided liver biopsy of conventional method (multiple liver punctures) versus coaxial method followed by needle tract plugging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 2, 2022
CompletedFirst Submitted
Initial submission to the registry
November 1, 2022
CompletedFirst Posted
Study publicly available on registry
November 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedNovember 14, 2022
November 1, 2022
1.1 years
November 1, 2022
November 10, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Safety of percutaneous liver biopsy
Biopsy-related bleeding * Minor bleeding is defined as presence of linear flow signal along the needle tract on Doppler exam. * Major bleeding is defined as bleeding which requires transfusion or vascular embolization.
During procedure
Safety of percutaneous liver biopsy
Biopsy-related bleeding * Minor bleeding is defined as presence of linear flow signal along the needle tract on Doppler exam. * Major bleeding is defined as bleeding which requires transfusion or vascular embolization.
Day 1 after procedure
Safety of percutaneous liver biopsy
Biopsy-related bleeding * Minor bleeding is defined as presence of linear flow signal along the needle tract on Doppler exam. * Major bleeding is defined as bleeding which requires transfusion or vascular embolization.
Day 7 after procedure
Secondary Outcomes (1)
Efficacy of percutaneous liver biopsy
1 week
Study Arms (2)
Conventional
ACTIVE COMPARATORPercutaneous liver biopsy is carried out through multiple punctures of liver capsule.
Coaxial/plugging
EXPERIMENTALPercutaneous liver biopsy is carried out through single puncture of liver capsule using coaxial needle and subsequent needle tract plugging.
Interventions
The conventional method utilizes a 18G biopsy gun to acquire three or more tissue cores with the corresponding number of liver capsule punctures. Plugging of the biopsy needle track is not performed.
The coaxial method utilizes a 17G coaxial needle with 18G biopsy gun to acquire three or more tissue cores with a single liver capsule puncture. Biopsy needle track is plugged using a slurry of gelatin particles (EGgel S Plus 2000-4000 μm).
Eligibility Criteria
You may qualify if:
- All adult patients aged 19 years or older in this institution
- Patients referred for imaging-guided percutaneous liver biopsy requiring three or more tissue cores
- Patients who understand and consent to enrollment in this study
- Target lesion diameter 1cm or larger, and the lesion is approachable under ultrasonography-guidance.
You may not qualify if:
- Patients with severe psychologic disorder or mental retardation
- Patients with poor cooperation
- Severe coagulopathy
- Hepatobiliary obstruction
- Acute hepatobiliary infection
- Large amount of ascites
- Amyloidosis
- Patients on antiplatelet/anticoagulant medication that cannot be discontinued for a specified period of time
- Other patients whom the researchers deem ineligible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yonsei University Health System, Severance Hospital
Seoul, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Seung-seob Kim
Severance hospitalDepartment of Radiology, Severance Hospital, Yonsei University College of Medicine, Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2022
First Posted
November 14, 2022
Study Start
August 2, 2022
Primary Completion
August 31, 2023
Study Completion
August 31, 2023
Last Updated
November 14, 2022
Record last verified: 2022-11